Evotec SE (EVOTF)
3.890
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
Evotec Shareholders Equity (Quarterly) : 760.96M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 760.96M |
| March 31, 2026 | 806.10M |
| December 31, 2025 | 955.65M |
| September 30, 2025 | 940.16M |
| June 30, 2025 | 992.83M |
| March 31, 2025 | 985.29M |
| December 31, 2024 | 986.34M |
| September 30, 2024 | 1.081B |
| June 30, 2024 | 1.084B |
| March 31, 2024 | 1.195B |
| December 31, 2023 | 1.237B |
| September 30, 2023 | 1.208B |
| June 30, 2023 | 1.281B |
| March 31, 2023 | |
| December 31, 2022 | 1.267B |
| September 30, 2022 | 1.204B |
| June 30, 2022 | 1.334B |
| March 31, 2022 | 1.457B |
| December 31, 2021 | 1.567B |
| September 30, 2021 | 1.150B |
| June 30, 2021 | 1.011B |
| March 31, 2021 | 932.07M |
| December 31, 2020 | 886.41M |
| September 30, 2020 | 554.40M |
| June 30, 2020 | 534.71M |
| Date | Value |
|---|---|
| March 31, 2020 | 537.07M |
| December 31, 2019 | 535.46M |
| September 30, 2019 | 503.44M |
| June 30, 2019 | 499.09M |
| March 31, 2019 | 502.35M |
| December 31, 2018 | 484.70M |
| September 30, 2018 | 452.26M |
| June 30, 2018 | 411.06M |
| March 31, 2018 | 416.05M |
| December 31, 2017 | 397.37M |
| September 30, 2017 | 375.08M |
| June 30, 2017 | 357.22M |
| March 31, 2017 | 333.98M |
| December 31, 2016 | 224.70M |
| September 30, 2016 | 216.87M |
| June 30, 2016 | 206.03M |
| March 31, 2016 | 206.82M |
| December 31, 2015 | 201.51M |
| September 30, 2015 | 198.00M |
| June 30, 2015 | 201.17M |
| March 31, 2015 | 175.41M |
| December 31, 2014 | 191.65M |
| September 30, 2014 | 196.59M |
| June 30, 2014 | 214.84M |
| March 31, 2014 | 214.96M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Sartorius AG | 3.227B |
| SCHOTT Pharma AG & Co. KGaA | 1.139B |
| Agilent Technologies, Inc. | 7.122B |
| Bio-Rad Laboratories, Inc. | 7.174B |
| Bruker Corp. | 2.381B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.800B |
| Total Liabilities (Quarterly) | 1.039B |
| Debt to Equity Ratio | 0.715 |
| Current Ratio | 2.333 |
| Net Debt Paydown Yield | -0.45% |